No painful procedure or biopsy needed. We can test our blood to diagnose and even predict cancer.
The Human Genome Project, a joint effort between the U.S. Department of Energy and the National Institutes of Health, began...more
The Food and Drug Administration’s approval of Guardant Health’s Guardant360 CDx assay marks a new era for genetic mutation testing in cancer treatment. On August 7, 2020, the FDA approved the first diagnostic test that...more